• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecular simulation analysis.

作者信息

Li Daoqun, Liu Yuwen, Li Kangxin, Zhang Leiliang

机构信息

Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

出版信息

J Infect. 2022 Oct;85(4):e99-e101. doi: 10.1016/j.jinf.2022.07.001. Epub 2022 Jul 8.

DOI:10.1016/j.jinf.2022.07.001
PMID:35810941
Abstract
摘要

相似文献

1
Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecular simulation analysis.通过特考韦瑞马靶向猴痘病毒和天花病毒的F13：分子模拟分析
J Infect. 2022 Oct;85(4):e99-e101. doi: 10.1016/j.jinf.2022.07.001. Epub 2022 Jul 8.
2
Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus.基于片段的方法鉴定了特考韦瑞玛特竞争性新型药物候选物，用于靶向猴痘病毒的 F13 蛋白。
Viruses. 2023 Feb 19;15(2):570. doi: 10.3390/v15020570.
3
Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.在非人类灵长类动物中联合使用特考韦瑞玛特和 ACAM2000TM：特考韦瑞玛特治疗对 ACAM2000 免疫原性和针对致死性猴痘病毒攻击的疗效的影响。
Vaccine. 2020 Jan 16;38(3):644-654. doi: 10.1016/j.vaccine.2019.10.049. Epub 2019 Oct 31.
4
New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.新型抗菌药物：特考韦瑞用于治疗人类猴痘病毒。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0122622. doi: 10.1128/aac.01226-22. Epub 2022 Nov 14.
5
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.天花潜在治疗药物溴昔洛韦的药代动力学和疗效在致命猴痘病毒动物模型中的研究。
mSphere. 2021 Feb 3;6(1):e00927-20. doi: 10.1128/mSphere.00927-20.
6
Structural insights into tecovirimat antiviral activity and poxvirus resistance.对替考韦瑞玛抗病毒活性和痘病毒耐药性的结构见解。
Nat Microbiol. 2025 Mar;10(3):734-748. doi: 10.1038/s41564-025-01936-6. Epub 2025 Feb 12.
7
Preliminary Screening and In Vitro Confirmation of Orthopoxvirus Antivirals.正痘病毒抗病毒药物的初步筛选及体外验证
Methods Mol Biol. 2019;2023:143-155. doi: 10.1007/978-1-4939-9593-6_9.
8
Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.治疗延迟对致死性猴痘病毒气雾感染恒河猴后替科韦利马特疗效的影响。
J Infect Dis. 2018 Sep 22;218(9):1490-1499. doi: 10.1093/infdis/jiy326.
9
Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects.获批用于天花的药物特考韦瑞马（Tpoxx）对猴痘的疗效：最新进展与未来展望
Int J Surg. 2023 May 1;109(5):1528-1530. doi: 10.1097/JS9.0000000000000077.
10
Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus.针对替考韦瑞马特的靶点F13蛋白进行药物筛选，作为猴痘病毒的潜在治疗方法。
J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.11.018. Epub 2022 Nov 25.

引用本文的文献

1
A review of Mpox: Biological characteristics, epidemiology, clinical features, diagnosis, treatment, and prevention strategies.猴痘综述：生物学特性、流行病学、临床特征、诊断、治疗及预防策略
Exploration (Beijing). 2024 Oct 8;5(2):20230112. doi: 10.1002/EXP.20230112. eCollection 2025 Apr.
2
Narciclasine inhibits vaccinia virus infection by activating the RhoA signaling pathway.水仙环素通过激活RhoA信号通路抑制痘苗病毒感染。
Biosaf Health. 2024 Nov 19;6(6):341-349. doi: 10.1016/j.bsheal.2024.11.002. eCollection 2024 Dec.
3
Structural insights into tecovirimat antiviral activity and poxvirus resistance.
对替考韦瑞玛抗病毒活性和痘病毒耐药性的结构见解。
Nat Microbiol. 2025 Mar;10(3):734-748. doi: 10.1038/s41564-025-01936-6. Epub 2025 Feb 12.
4
Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs: A WEB prediction approach.猴痘病毒核心治疗靶点的鉴定及药物重新利用潜力：一种网络预测方法。
PLoS One. 2024 Dec 6;19(12):e0303501. doi: 10.1371/journal.pone.0303501. eCollection 2024.
5
Characterization of a unique catechol-O-methyltransferase as a molecular drug target in parasitic filarial nematodes.鉴定独特儿茶酚-O-甲基转移酶作为寄生性丝虫的分子药物靶点。
PLoS Negl Trop Dis. 2024 Aug 30;18(8):e0012473. doi: 10.1371/journal.pntd.0012473. eCollection 2024 Aug.
6
Exploring monkeypox virus proteins and rapid detection techniques.探索猴痘病毒蛋白和快速检测技术。
Front Cell Infect Microbiol. 2024 May 28;14:1414224. doi: 10.3389/fcimb.2024.1414224. eCollection 2024.
7
The global patent landscape of emerging infectious disease monkeypox.新兴传染病猴痘的全球专利全景。
BMC Infect Dis. 2024 Apr 15;24(1):403. doi: 10.1186/s12879-024-09252-w.
8
Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.猴痘（原名猴痘）：发病机制、预防和治疗。
Signal Transduct Target Ther. 2023 Dec 27;8(1):458. doi: 10.1038/s41392-023-01675-2.
9
Pharmacoinformatics-Based Approach for Uncovering the Quorum-Quenching Activity of Phytocompounds against the Oral Pathogen, .基于药物信息学的方法揭示植物化合物对口腔病原体的群体感应淬灭活性
Molecules. 2023 Jul 19;28(14):5514. doi: 10.3390/molecules28145514.
10
Using AlphaFold Predictions in Viral Research.在病毒研究中使用AlphaFold预测结果。
Curr Issues Mol Biol. 2023 Apr 21;45(4):3705-3732. doi: 10.3390/cimb45040240.